{"id":"doi:10.1016/j.arr.2023.102012","kind":"review","title":"Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis","authors":["Danko Jeremic","Juan D. Navarro‐López","Lydia Jiménez‐Díaz"],"author_count":3,"year":2023,"published":"2023-07-07","venue":"Ageing Research Reviews","cited_by":77,"doi":"10.1016/j.arr.2023.102012","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.arr.2023.102012","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.arr.2023.102012","updated":null,"pmid":"37423541","pmcid":null,"openalex_id":"W4383532638","pdf_url":null,"abstract":null,"abstract_license":null,"license":"other-oa","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}